Kirn David
See Remarks
Kirn David has filed 6 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2026. 6 of those filings fall inside the rolling window. Most recent filing: Aug 21, 2026.
On the most recent filing, Kirn David is listed as See Remarks at 4D Molecular Therapeutics, Inc. Inside the rolling window, Kirn David reported no open-market purchases and 7 open-market sales totaling $3.4M in FDMT. The largest disclosed transaction in the window is a sale of 114,746 FDMT shares on Jun 22, 2026, worth $1.2M.
Companies traded
Other insiders at FDMT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.4M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Kirn David made?
Kirn David has filed 6 SEC Form 4 filings (10 transaction rows) across 1 company since 2026.
Which companies does Kirn David trade?
Kirn David has filed SEC Form 4 disclosures for 1 company, including FDMT.
When was Kirn David's most recent SEC Form 4 filing?
Kirn David's most recent SEC Form 4 filing on Tracefour is dated Aug 21, 2026.
What is Kirn David's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Kirn David is listed as See Remarks.
What is Kirn David's total buy and sell value in the current window?
Inside the rolling retention window, Kirn David bought $0 and sold $3.4M based on SEC Form 4 filings.
What was Kirn David's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 114,746 FDMT shares on 2026-06-22, worth $1.2M, per SEC Form 4 filings.